Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BNTC | US
0.20
2.15%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
30/08/2024
9.24
8.99
9.25
8.78
Benitec Biopharma Inc. a development-stage biotechnology company focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301 an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward California.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
31.0%1 month
59.4%3 months
73.7%6 months
104.1%-
-
7.85
0.03
0.02
0.27
10.93K
-
-21.41M
93.25M
93.25M
-
-307.03K
-
12.50
-267.59
2.42
0.88
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.84
Range1M
2.65
Range3M
5.14
Rel. volume
0.62
Price X volume
114.39K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.7602 | 94.78M | -1.38% | n/a | -148.05% |
Relmada Therapeutics Inc | RLMD | Drug Manufacturers-Specialty & Generic | 2.8 | 84.49M | 6.06% | n/a | 0.00% |
Universe Pharmaceuticals INC | UPC | Drug Manufacturers-Specialty & Generic | 3.25 | 76.85M | -0.61% | n/a | 13.87% |
Silver Spike Investment Corp. Common Stock | SSIC | Drug Manufacturers-Specialty & Generic | 11.46 | 71.22M | -0.17% | 12.73 | 0.00% |
Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 5.14 | 66.61M | -1.91% | 5.00 | 27.85% |
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 3.3 | 63.19M | 3.55% | n/a | 8.44% |
Orexo AB (publ) | ORXOY | Drug Manufacturers-Specialty & Generic | 1.51 | 55.31M | 1.48% | n/a | 0.00% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.46 | 55.27M | 0.00% | n/a | 25.73% |
Qilian International Holding Group Limited | QLI | Drug Manufacturers-Specialty & Generic | 6.97 | 53.06M | 4.81% | n/a | 1.35% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.48 | 45.94M | 3.50% | n/a | 318.92% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Culp Inc | CULP | Textile Manufacturing | 5.02 | 62.60M | 0.20% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.34 | 28.51M | 13.04% | n/a | 16.03% |
ILAG | ILAG | Building Products & Equipment | 1.25 | 22.57M | 6.84% | n/a | 5.48% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.76 | 11.69M | 7.80% | n/a | 422.08% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2495 | 3.93M | 5.94% | n/a | 0.97% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.391 | 3.72M | -6.28% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.45 | 3.70M | 13.28% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.47 | 2.11M | -7.84% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.28 | 0 | -0.07% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.27 | - | Cheaper |
Ent. to Revenue | 10,929.40 | - | Expensive |
PE Ratio | - | 28.13 | - |
Price to Book | 7.85 | 11.07 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 73.73 | - | Par |
Debt to Equity | 0.03 | -0.91 | Expensive |
Debt to Assets | 0.02 | 0.45 | Cheaper |
Market Cap | 93.25M | - | Emerging |